Dr. Pergam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1100 Fairview Ave, N E4-100
Seattle, WA 98109Phone+1 206-667-7126Fax+1 206-667-4411
Education & Training
- U Washington Affil Hosps2005 - 2008
- University of New Mexico School of MedicineResidency, Internal Medicine, 1998 - 2001
- University of Nebraska College of MedicineClass of 1998
Certifications & Licensure
- MT State Medical License 2022 - 2026
- WA State Medical License 2017 - 2026
- NM State Medical License 1998 - 2007
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Nozin in Preventing Respiratory Viral Infections in Patients Undergoing Stem Cell Transplant, PREV-NOSE STUDY Start of enrollment: 2019 Sep 03
- Olorofim Aspergillus Infection Study Start of enrollment: 2022 Mar 31
Roles: Contact
Publications & Presentations
PubMed
- 1 citationsCOVID-19 Outcomes Among Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Recipients in the Era of SARS-CoV-2 Omicron Variants and COVID-19 Therapeutics.Emily A Rosen, Elizabeth M Krantz, Denise J McCulloch, Marie H Wilson, Frank Tverdek
Transplantation and Cellular Therapy. 2024-11-01 - 1 citationsHow Immunocompromised Hosts Were Left Behind in the Quest to Control the COVID-19 Pandemic.Michael Boeckh, Steven A Pergam, Ajit P Limaye, Janet Englund, Lawrence Corey
Clinical Infectious Diseases. 2024-10-15 - Epidemiology and Outcomes of RecurrentInfection Among Hematopoietic Cell Transplant Recipients: A Single-center, Retrospective 10-year Study.Eduardo Sanchez, Elizabeth M Krantz, Zahra Kassamali Escobar, Frank Tverdek, Emily A Rosen
Open Forum Infectious Diseases. 2024-10-01
Journal Articles
- How Clean Is the Linen at My Hospital? The Mucorales on Unclean Linen Discovery Study of Large United States Transplant and Cancer CentersSteven A Pergam, Jose Vazquez, Pranatharthi Chandrasekar, Kieren A Marr, Sankar Swaminathan, Michele I Morris, John R Wingard, Lilian Abbo, Sanjay G Revankar, Becky Sm..., Clinical Infectious Diseases
- A Randomized, Placebo-Controlled Trial of Fidaxomicin for Prophylaxis of Clostridium Difficile Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transpl...Kevin Gregg, Javier A Adachi, Steven A Pergam, Clinical Infectious Diseases
Authored Content
- Hemostatic Biomarkers Predict Risk of Thromboembolism (TE), Severe COVID-19 and Mortality: A Report from the National Cancer Institute COVID-19 in Cancer Patients Study (NCCAPS)December 2022
Press Mentions
- FDA Panel Backs Pfizer's RSV Vaccine for Older AdultsFebruary 28th, 2023
- FDA Panel Narrowly Endorses Pfizer Vaccine for RSV in Older AdultsFebruary 28th, 2023
- FDA Experts Are Still Puzzled over Who Should Get Which Covid Shots and WhenJanuary 27th, 2023
- Join now to see all
Grant Support
- Natural Killer Cell Receptor Diversity And CMV In Hematopoietic Cell TransplantatNational Heart, Lung, And Blood Institute2009–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: